Eliminate cravings that sabotage your health goals Supercharge your metabolism through superfood science Deliciously boost GLP-1, immunity, gut health & focus Enjoy three forms of caffeine for the all-day energy you deserve Stay on track with your healthy eating habits Ditch the long-lines & over-priced alternatives NEW YEAR SALE NOW LIVE BUNDLE UP & Save Up To 50% Off Be quick, stock is limited & we're selling out fast
In the ELIXA trial, Pfeffer et al 27 evaluated the effect of lixisenatide in patients with type 2 diabetes with myocardial infarction or unstable angina admission in the previous 180 days
Frias JP, Nauck MA, Van J et al (2020) Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
[PubMed] [Google Scholar] 93.Gavrilova S.I., Kalyn I.B., Kolykhalov I.V., Roshchina I.F., Selezneva N.D
Jean-Pierre Raufman, M.D., Baltimore VA Medical Center (formerly with State University of New York Health Science Center) Selected publications: Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom
No medical, therapeutic, or diagnostic claims are made or implied